Search for: "Sandoz, Inc"
Results 521 - 540
of 679
Sorted by Relevance
|
Sort by Date
1 Nov 2011, 6:08 am
Inc. have experienced problems. [read post]
7 Jun 2007, 10:52 am
Pfizer, Inc., 198 F. [read post]
9 May 2017, 4:42 am
That was the issue before Arnold J. in his latest judgment considering the SPC Regulation in (1) Sandoz Limited (2) Hexal AG v (1) G.D. [read post]
30 Sep 2015, 4:30 am
Sandoz Pharmaceuticals Corp., 172 F. [read post]
17 Feb 2017, 12:21 pm
Sandoz v. [read post]
20 Jun 2016, 10:20 am
Sandoz and Sandoz v. [read post]
8 Jul 2010, 3:30 am
Sandoz Pharm. [read post]
4 Jun 2009, 5:30 am
Sandoz, Inc., a decision that just screams for Congress to codify Rule 56 and settle once and for all the duty of candor that is owed to the Patent Office during the patent application process. [read post]
24 Dec 2012, 9:58 am
Sandoz Pharms. [read post]
23 Jun 2014, 12:57 pm
” Matrixx Initiatives, Inc. v. [read post]
17 Oct 2015, 5:29 am
No serious observer or scholar of the law of evidence can deny that the lower federal courts have applied Daubert and its progeny, and the revised Federal Rule of Evidence 702, inconstantly and inconsistently, in their decisions to admit or exclude proffered expert witness opinion testimony. [read post]
14 Jul 2021, 8:09 pm
Inc. v. [read post]
23 Sep 2017, 12:39 pm
Sandoz, Inc., 789 F.3d 1335, 1344-45 (Fed. [read post]
1 Jun 2011, 11:22 am
Sandoz, Inc., 566 F.3d 1282, 1298 (Fed. [read post]
13 May 2010, 4:58 pm
Sandoz, Inc. [read post]
20 Jun 2011, 7:01 pm
Sandoz, Inc. [read post]
11 May 2011, 4:54 am
Allergan, Inc. [read post]
10 Apr 2012, 1:15 pm
The Loryna and Syeda OCs are made and sold by Sandoz, Inc. [read post]
14 Jun 2017, 4:18 am
Sandoz Inc. [read post]
17 Oct 2008, 1:32 pm
Proposed EU information laws on prescription drugs (IPmed) Iceland: Supplementary Protection Certificates (SPCs) in Iceland (The SPC blog) India: Roche implements 'mass serialisation' anti-counterfeiting technology (Spicy IP) Indonesia: Patent application on oil palm hybrids (navigating the patent maze) United States: New PMCA research: State legislative proposals restricting access to generic medicines would increase cost $29 billion over 10 years (GenericsWeb) US: Pharmaceutical… [read post]
